The Courts’ actions in these matters will help to promote the judicial efficiency of both proceedings and will simplify the process for filing lawsuits in the future.
New York, New York (PRWEB) March 26, 2015
Xarelto lawsuits (http://www.xareltolawsuit2015.com/) continue to move forward nationwide, with the issuance of new court documents in consolidated litigations currently underway in Pennsylvania and Louisiana. According to an Order dated March 24th, the Court overseeing the federal multidistrict litigation established for Xarelto injury claims in the U.S. District Court, Eastern District of Louisiana will now allow plaintiffs to file cases directly in the proceeding. (In Re: Xarelto Products Liability Litigation, No. 2592)
Court papers filed in Pennsyvania’s Philadelphia Court of Common Pleas on March 23rd indicate that a Master Long Form Complaint has been approved for use by all plaintiffs who choose to bring suit in that state’s Xarelto mass tort proceeding. (In Re: Xarelto Litigation, Case ID 150102349)
“Both of these consolidated litigations were established to allow Xarelto lawsuits alleging similar allegations of fact to undergo coordinated pretrial proceedings. The Courts’ actions in these matters will help to promote the judicial efficiency of both proceedings and will simplify the process for filing lawsuits in the future,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts on behalf of individuals who allegedly suffered a life-threatening internal bleeding episode, a stroke, deep vein thrombosis or pulmonary embolism due to their use of this blood thinner.
Xarelto is a new-generation anticoagulant that was initially approved by the U.S. Food & Drug Administration in 2011. The blood thinner is now indicated for prevention of strokes in people with atrial fibrillation; the treatment of deep vein thrombosis and pulmonary embolism; and the prevention of deep vein thrombosis in patients undergoing hip or knee replacement surgery. Like any anticoagulant, Xarelto can sometimes cause internal bleeding. However, there is currently no approved antidote for reversing Xarelto bleeding.*
Court documents indicate that more than 300 Xarelto lawsuits have been filed in the federal litigation underway in Louisiana, while at least 160 cases involving similar allegations are pending in the Pennsylvania mass tort. Among other things, plaintiffs claim that the medication was wrongly marketed as an improvement over warfarin, a blood thinner that has been in use for decades. The lawsuits point out that unlike Xarelto, bleeding associated with warfarin can be stopped via the administration of vitamin K.
Xarelto patients who allegedly experienced life-threatening episodes of internal bleeding and other complications related to its use may be entitled to compensation for medical bills, lost wages, pain and suffering and more. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.
*fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, March 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP